Global Trade Alert
Global Trade Alert

Back to state act

United States of America: Agreement with Novartis on Most-Favoured-Nation drug pricing and tariff exemption

Description

On 19 December 2025, the U.S. Administration announced an agreement with Novartis. Under the agreement, Novartis committed to make investments in R&D and manufacturing in the United States. In ret...

Sign in to see full description

Intervention Details

Intervention Type

FDI: Financial incentive

MAST Chapter

L: Subsidies (excl. export subsidies)

Implementation date

No implementation date

Revocation date

No revocation date

Implementation level

National

Affected flow

Inward

Announced as temporary

No

Eligible firms

firm-specific

Affected Trading Partners

Graph

Table

Affected Sectors

Sign in to access 1 sectors

Affected Products

Sign in to access 5 products

Threads

See all

This intervention is not part of any Thread yet.